Because of their effect on heart rhythms, never use more of an SABA than prescribed. On rare occasions overuse of albuterol or levalbuterol has causedmyocardial infarction(heart attack) or stroke.15 Beta2-agonists are known to interact with certain classes of drugs. In some cases, ...
Introduction: SABA over-use in asthma is harmful for patients and the environment. The SENTINEL Project utilised a co-designed intervention to identify and address SABA over-use with the aim of improving patient outcomes and reducing the environmental impact of asthma and its treatment. SENTINEL ...
Beta2 agonists increase the severity of asthma through enhanced bronchial hyperresponsiveness and reduced lung function. Also, it has been shown that overreliance on SABA delays recognition of a potentially life-threatening asthma attack. We believe that overreliance on SABA in asthma is also an ...
Overuse of short-acting beta-agonists (SABA) is described in asthma, but little is known about overuse of SABA in chronic obstructive pulmonary disease (COPD). Methods Prospective 3-month cohort study of patients with moderate-to-severe COPD who were provided a portable electronic inhaler sensor ...
Overuse of short-acting beta-agonists (SABA) is described in asthma, but little is known about overuse of SABA in chronic obstructive pulmonary disease (COPD). Methods Prospective 3-month cohort study of patients with moderate-to-severe COPD who were provided a portable electronic inhaler sensor ...
SABA short-acting beta2 agonist, OCS oral corticosteroids Full size image Almost 19% of patients on PRT dispensed at least 1 package of OCS and 11% of the OCS users dispensed at least 4 packages. Fitzgerald et al. [20] reported that 13% of asthma patients used OCS. Cumulative exposure ...
Results demonstrate the efficacy of short-acting beta-agonist (SABA) delivered by metered-dose inhaler as first-line therapy for younger and older children (hospital admission decreased by 44% in younger children, and ED length of stay decreased by 33 min in older children). Short-acting ...
This post-hoc analysis of the SABINA III study evaluated the association of short-acting β2-agonist (SABA) prescriptions and self-reported over-the-counter (OTC) SABA purchase in the previous 12 months with asthma-related outcomes using multivariable regression models in 4556 patients (mean age,...
One goal of guideline-based asthma therapy is minimal use of short-acting β2 agonist (SABA) medications. Inner-city children with asthma are known to have high SABA use. Objective To examine factors associated with high SABA use in inner-city children with asthma. Methods One hundred inner-...
The study objective was to evaluate 30-day readmission rates among COPD patients who received arformoterol, a nebulized long-acting beta agonist, or nebulized short-acting beta agonists (neb-SABA) during an inpatient stay. Methods Data ... V Bollu,SB Robinson,J Karafilidis,... - 《Value in...